MedPath

Evaluation of the effect of L-carnitine administration on peritoneal membrane function in peritoneal dialysis patients.

Not Applicable
Conditions
Secondary carnitine deficiency
Registration Number
JPRN-UMIN000031514
Lead Sponsor
Division of Nephrology, Department on Medicine, Kurume University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients under the age of 20 years old 2.Patients who are contraindicated in the package insert of Levocarnitine 3.Patients undergoing combination therapy with peritoneal dialysis and hemodialysis 4.Pregnant woman, or a woman who have possibility of pregnancy 5.Others not inadequate judged by a physician 6.Patients who do not obtain consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath